Promising combo for brain metastases halted early
Disease control
Terminated
This study tested a combination of two drugs, abemaciclib and elacestrant, in women with a type of breast cancer (HR+/Her2-) that had spread to the brain. The goal was to see if the drugs could shrink brain tumors and control the disease. Only 5 people enrolled before the study w…
Phase: PHASE1, PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated May 17, 2026 03:08 UTC